MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/bjh.16329

Медицинская библиотека · British journal of haematology · 2019

Mucormycosis in children with haematological malignancies is a salvageable disease: a report from the Israeli Study Group of Childhood Leukemia.

Elitzur Sarah, Arad-Cohen Nira, Barg Assaf, Litichever Naomi, Bielorai Bella, Elhasid Ronit, Fischer Salvador, Fruchtman Yariv, Gilad Gil, Kapelushnik Joseph, Kharit Mira, Konen Osnat, Laor Ruth, Levy Itzhak, Raviv Dror, Shachor-Meyouhas Yael, Shvartser-Beryozkin Yulia, Toren Amos, Yaniv Isaac, Nirel Ronit, Izraeli Shai, Barzilai-Birenboim Shlomit

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Mucormycosis has emerged as an increasingly important cause of morbidity and mortality in immunocompromised patients, but contemporary data in children are lacking. We conducted a nationwide multicentre study to investigate the characteristics of mucormycosis in children with haematological malignancies. The cohort included 39 children with mucormycosis: 25 of 1136 children (incidence 2·2%) with acute leukaemias prospectively enrolled in a centralized clinical registry in 2004-2017, and an additional 14 children with haematological malignancies identified by retrospective search of the databases of seven paediatric haematology centres. Ninety-two percent of mucormycosis cases occurred in patients with acute leukaemias. Mucormycosis was significantly associated with high-risk acute lymphoblastic leukaemia (OR 3·75; 95% CI 1·51-9·37; P = 0·004) and with increasing age (OR 3·58; 95% CI 1·24-9·77; P = 0·01). Fifteen patients (38%) died of mucormycosis. Rhinocerebral pattern was independently associated with improved 12-week survival (OR 9·43; 95% CI 1·47-60·66; P = 0·02) and relapsed underlying malignancy was associated with increased 12-week mortality (OR 6·42; 95% CI, 1·01-40·94; P = 0·05). In patients receiving frontline therapy for their malignancy (n = 24), one-year cumulative mucormycosis-related mortality was 21 ± 8% and five-year overall survival was 70 ± 8%. This largest paediatric population-based study of mucormycosis demonstrates that children receiving frontline therapy for their haematological malignancy are often salvageable.

Для цитирования: Elitzur Sarah, Arad-Cohen Nira, Barg Assaf, Litichever Naomi, Bielorai Bella, Elhasid Ronit, Fischer Salvador, Fruchtman Yariv, Gilad Gil, Kapelushnik Joseph, Kharit Mira, Konen Osnat, Laor Ruth, Levy Itzhak, Raviv Dror, Shachor-Meyouhas Yael, Shvartser-Beryozkin Yulia, Toren Amos, Yaniv Isaac, Nirel Ronit, Izraeli Shai, Barzilai-Birenboim Shlomit. Mucormycosis in children with haematological malignancies is a salvageable disease: a report from the Israeli Study Group of Childhood Leukemia.. British journal of haematology. 2019. DOI: 10.1111/bjh.16329.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.